Ariake Biotech Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-07-2024
- Paid Up Capital ₹ 0.10 M
as on 11-07-2024
- Company Age 29 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.03 M
as on 11-07-2024
- Revenue -54.91%
(FY 2020)
- Profit -153.01%
(FY 2020)
- Ebitda -30.14%
(FY 2020)
- Net Worth -0.86%
(FY 2020)
- Total Assets -0.01%
(FY 2020)
About Ariake Biotech Solutions
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.03 M.
Sathak Shaw, Zarook Shah, Ramamurthy Pandurangan, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909TN1995PTC033736
- Company No.
033736
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ariake Biotech Solutions?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Zarook Shah  | Director | 24-Jan-2023 | Current |
| Sathak Shaw | Director | 27-May-2005 | Current |
| Ramamurthy Pandurangan | Director | 27-May-2005 | Current |
| Naseema Beevi | Director | 16-Dec-1995 | Current |
Financial Performance of Ariake Biotech Solutions.
Ariake Biotech Solutions Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 54.91% decrease. The company also saw a substantial fall in profitability, with a 153.01% decrease in profit. The company's net worth dipped by a decrease of 0.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ariake Biotech Solutions?
In 2019, Ariake Biotech Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Precious Hana Holdings LlpActive 11 years 11 monthsSathak Shaw, Zarook Shah and 1 more are mutual person
- Paramount Builders (Chennai) Private LimitedActive 32 years 6 months
Sathak Shaw, Zarook Shah and 1 more are mutual person
- Precious Microtech Private LimitedActive 26 years 8 months
Sathak Shaw, Zarook Shah and 1 more are mutual person
- Southern Chemicals And Salts (India) Private LimitedActive 15 years 8 months
Sathak Shaw and Zarook Shah are mutual person
- S R Environ Private LimitedActive 15 years 11 months
Sathak Shaw and Ramamurthy Pandurangan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karur Vysya Bank Ltd Creation Date: 28 May 2015 | ₹0.65 M | Open |
The Karur Vysya Bank Limited Creation Date: 27 Sep 2014 | ₹0.38 M | Open |
How Many Employees Work at Ariake Biotech Solutions?
Unlock and access historical data on people associated with Ariake Biotech Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ariake Biotech Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ariake Biotech Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
